Posted Jun. 29, 2012 at 12:09 p.m.

Premium Lock GSK extends $2.6B hostile takeover bid for HGSI

Published: 2012-06-29 12:09:27
Updated: 2012-06-29 12:09:27


GlaxoSmithKline extended its hostile $2.6 billion takeover offer for Human Genome Sciences Inc. a second time to allow investors to consider any competing bids the U.S. biotechnology company may receive....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders